Obesity Treatment Market - Global Forecast 2026-2032

The Obesity Treatment Market is undergoing pivotal transformation, as evolving clinical innovations integrate with shifting patient expectations, payer requirements, and emerging commercial strategies. Senior decision-makers are increasingly seeking trusted, actionable insights to inform their market approach, operational plans, and long-term investments within this dynamic landscape.

Market Snapshot: Obesity Treatment Market Growth, Size, and Prospects

The Obesity Treatment Market grew from USD 16.69 billion in 2025 to USD 18.02 billion in 2026. It is expected to continue growing at a CAGR of 8.45%, reaching USD 29.46 billion by 2032.

Scope & Segmentation of the Obesity Treatment Market

This report delivers a granular exploration of the obesity treatment ecosystem, covering innovations and strategies reshaping clinical and commercial models worldwide. The scope spans product, technology, and stakeholder considerations essential for informed leadership decisions.

Treatment Modalities: Pharmacotherapy (including over-the-counter and prescription medicines), surgical interventions, and device-driven approaches.
Drug Classes: Appetite suppressants, GLP-1 receptor agonists, metabolism modulators, and lipase inhibitors, each offering unique profiles and barriers to adoption.
Administration Routes: Oral and parenteral solutions, influencing patient adherence and delivery infrastructure requirements.
Age Cohorts: Adults, elderly, and pediatric patients, with tailored protocols for safety, dosing, and ongoing support.
Distribution Channels: Offline and online retail pharmacies, direct-to-clinic distribution, and specialty outlets.
End-Users: Hospitals, specialty clinics, and wellness centers, each shaping patient flow and multi-disciplinary care.
Regional Markets: Americas, Europe, Middle East & Africa, and Asia-Pacific—reflecting regulatory, economic, and clinical practice variations that influence market expansion and patient access.
Technology Innovations: Integration of digital adherence tools, remote monitoring, and bundled care solutions to support patient-centered outcomes.

Key Takeaways: Strategic Insights for Stakeholder Decision-Making

Transformation is driven by the interplay between new pharmacotherapies, procedural advancements, and evolving patient care pathways, necessitating adaptability from both product developers and service providers.
Shifting patient expectations underscore the need for therapies compatible with daily routines, minimizing adverse effects, and aligning with holistic wellness goals.
Payers are moving toward value-based care frameworks, with reimbursement increasingly conditional on demonstrated clinical and economic impact.
The regulatory environment is adapting to long-term, outcomes-driven evidence requirements, impacting clinical trials, post-approval monitoring, and stakeholder engagement strategies.
Cross-sector partnerships and innovative distribution strategies are essential to accelerate market access and secure competitive advantage.
All stakeholders must synchronize evidence generation, pragmatic delivery models, and regional nuances to drive sustainable growth.

Assessing Tariff Impact on the Obesity Treatment Value Chain

Changes in United States tariff policies are directly influencing cross-border supply chains, raw material sourcing, and manufacturing decisions. Increased import costs on key pharmaceutical ingredients and device components are prompting companies to reevaluate supplier contracts, diversify sourcing strategies, and consider regionalizing production. These changes affect lead times, pricing flexibility, and overall market responsiveness. Heightened tariffs also encourage organizations to invest in domestic capabilities and redesign product formulations, ensuring supply resilience and supporting continued patient access despite fluctuating trade measures.

Methodology & Data Sources

This report’s research is built on structured interviews with clinicians, payers, supply chain experts, and pharma leaders, supplemented by expert validation panels and secondary literature synthesis. Rigorous quantitative benchmarking, systematic qualitative coding, and layered quality controls ensure reliable, decision-grade data supporting every insight.

Why This Report Matters for the Obesity Treatment Market

Equips executives, payers, and clinicians with forward-looking guidance to evaluate innovation, regulatory, and reimbursement shifts within the primary obesity treatment market.
Enables more precise segmentation, go-to-market strategy, and risk mitigation by analyzing technology adoption, regional dynamics, and evolving patient requirements.
Supports operational planning, partnership development, and investment prioritization through actionable, data-driven forecasts and trend mapping.

Conclusion

Obesity treatment is evolving through the combined impact of innovation, regulation, and commercial reorientation. By leveraging the actionable insights in this report, stakeholders can chart a course toward improved patient outcomes and resilient, sustainable business models.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Obesity Treatment Market, by Treatment Type

8.1. Pharmacotherapy
8.1.1. Over-The-Counter Drugs
8.1.2. Prescription Medications
8.2. Surgical Procedures
8.2.1. Bariatric Surgery
8.2.2. Gastric Bypass
8.2.3. Laparoscopic Surgery

9. Obesity Treatment Market, by Drug Class

9.1. Appetite Suppressants
9.2. GLP-1 Receptor Agonists
9.3. Lipase Inhibitors
9.4. Metabolism Boosters

10. Obesity Treatment Market, by Route of Administration

10.1. Oral
10.2. Parenteral

11. Obesity Treatment Market, by Patient Age Group

11.1. Adults
11.2. Elderly
11.3. Pediatric

12. Obesity Treatment Market, by Distribution Channel

12.1. Offline Retail
12.2. Online Retail

13. Obesity Treatment Market, by End-User

13.1. Hospitals & Clinics
13.2. Specialty Clinics
13.3. Weight Loss & Wellness Centers

14. Obesity Treatment Market, by Region

14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific

15. Obesity Treatment Market, by Group

15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO

16. Obesity Treatment Market, by Country

16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea

17. United States Obesity Treatment Market
18. China Obesity Treatment Market

19. Competitive Landscape

19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. AbbVie Inc.
19.6. Apollo Endosurgery, Inc.
19.7. AstraZeneca PLC
19.8. Atkins Nutritionals, Inc.
19.9. BTL Aesthetics
19.10. C.H. Boehringer Sohn AG & Ko. KG
19.11. Eli Lilly and Company
19.12. F. Hoffmann-La Roche Ltd
19.13. GlaxoSmithKline plc.
19.14. Herbalife Ltd.
19.15. Johnson & Johnson Services, Inc.
19.16. Kellogg Company
19.17. Medtronic PLC
19.18. Merck & Co.
19.19. Novo Nordisk A/S
19.20. NutriSystem, Inc.
19.21. Olympus Corporation
19.22. Pfizer, Inc.
19.23. ReShape Lifesciences, Inc.
19.24. Rhythm Pharmaceuticals, Inc.
19.25. Sanofi SA
19.26. Takeda Pharmaceutical Company Limited
19.27. Viking Therapeutics, Inc.
19.28. VIVUS LLC
19.29. Zealand Pharma A/S

List of Figures

FIGURE 1. GLOBAL OBESITY TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL OBESITY TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL OBESITY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL OBESITY TREATMENT MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL OBESITY TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL OBESITY TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES OBESITY TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA OBESITY TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL OBESITY TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL OBESITY TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL OBESITY TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL OBESITY TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PRESCRIPTION MEDICATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PRESCRIPTION MEDICATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PRESCRIPTION MEDICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL OBESITY TREATMENT MARKET SIZE, BY BARIATRIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL OBESITY TREATMENT MARKET SIZE, BY BARIATRIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL OBESITY TREATMENT MARKET SIZE, BY BARIATRIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL OBESITY TREATMENT MARKET SIZE, BY GASTRIC BYPASS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL OBESITY TREATMENT MARKET SIZE, BY GASTRIC BYPASS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL OBESITY TREATMENT MARKET SIZE, BY GASTRIC BYPASS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL OBESITY TREATMENT MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL OBESITY TREATMENT MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL OBESITY TREATMENT MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL OBESITY TREATMENT MARKET SIZE, BY APPETITE SUPPRESSANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL OBESITY TREATMENT MARKET SIZE, BY APPETITE SUPPRESSANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL OBESITY TREATMENT MARKET SIZE, BY APPETITE SUPPRESSANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL OBESITY TREATMENT MARKET SIZE, BY GLP-1 RECEPTOR AGONISTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL OBESITY TREATMENT MARKET SIZE, BY GLP-1 RECEPTOR AGONISTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL OBESITY TREATMENT MARKET SIZE, BY GLP-1 RECEPTOR AGONISTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL OBESITY TREATMENT MARKET SIZE, BY LIPASE INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL OBESITY TREATMENT MARKET SIZE, BY LIPASE INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL OBESITY TREATMENT MARKET SIZE, BY LIPASE INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL OBESITY TREATMENT MARKET SIZE, BY METABOLISM BOOSTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL OBESITY TREATMENT MARKET SIZE, BY METABOLISM BOOSTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL OBESITY TREATMENT MARKET SIZE, BY METABOLISM BOOSTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PARENTERAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PARENTERAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ELDERLY, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ELDERLY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ELDERLY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL OBESITY TREATMENT MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL OBESITY TREATMENT MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL OBESITY TREATMENT MARKET SIZE, BY OFFLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL OBESITY TREATMENT MARKET SIZE, BY OFFLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL OBESITY TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL OBESITY TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL OBESITY TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL OBESITY TREATMENT MARKET SIZE, BY WEIGHT LOSS & WELLNESS CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL OBESITY TREATMENT MARKET SIZE, BY WEIGHT LOSS & WELLNESS CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL OBESITY TREATMENT MARKET SIZE, BY WEIGHT LOSS & WELLNESS CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL OBESITY TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS OBESITY TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 110. EUROPE OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. EUROPE OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 112. EUROPE OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 113. EUROPE OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 114. EUROPE OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 115. EUROPE OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 116. EUROPE OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 117. EUROPE OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 118. EUROPE OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 121. MIDDLE EAST OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 123. MIDDLE EAST OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 124. MIDDLE EAST OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 125. MIDDLE EAST OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 126. MIDDLE EAST OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 127. MIDDLE EAST OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 128. AFRICA OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. AFRICA OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 130. AFRICA OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 131. AFRICA OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 132. AFRICA OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 133. AFRICA OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 134. AFRICA OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 135. AFRICA OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 136. AFRICA OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL OBESITY TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 147. ASEAN OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. ASEAN OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 149. ASEAN OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 150. ASEAN OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 151. ASEAN OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 152. ASEAN OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 153. ASEAN OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 154. ASEAN OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 155. ASEAN OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 156. GCC OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. GCC OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 158. GCC OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 159. GCC OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 160. GCC OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 161. GCC OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 162. GCC OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 163. GCC OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 164. GCC OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 165. EUROPEAN UNION OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 168. EUROPEAN UNION OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 169. EUROPEAN UNION OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 170. EUROPEAN UNION OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 174. BRICS OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. BRICS OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 176. BRICS OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 177. BRICS OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 178. BRICS OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 179. BRICS OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 180. BRICS OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 181. BRICS OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 182. BRICS OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 183. G7 OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. G7 OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 185. G7 OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 186. G7 OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 187. G7 OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 188. G7 OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 189. G7 OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 190. G7 OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 191. G7 OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 192. NATO OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. NATO OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 194. NATO OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 195. NATO OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 196. NATO OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 197. NATO OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 198. NATO OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 199. NATO OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 200. NATO OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. UNITED STATES OBESITY TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 203. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 204. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 205. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 206. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 207. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 208. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 209. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 210. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 211. CHINA OBESITY TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 212. CHINA OBESITY TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 213. CHINA OBESITY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 214. CHINA OBESITY TREATMENT MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
TABLE 215. CHINA OBESITY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 216. CHINA OBESITY TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 217. CHINA OBESITY TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 218. CHINA OBESITY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 219. CHINA OBESITY TREATMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Obesity Treatment market report include:

AbbVie Inc.
Apollo Endosurgery, Inc.
AstraZeneca PLC
Atkins Nutritionals, Inc.
BTL Aesthetics
C.H. Boehringer Sohn AG & Ko. KG
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc.
Herbalife Ltd.
Johnson & Johnson Services, Inc.
Kellogg Company
Medtronic PLC
Merck & Co.
Novo Nordisk A/S
NutriSystem, Inc.
Olympus Corporation
Pfizer, Inc.
ReShape Lifesciences, Inc.
Rhythm Pharmaceuticals, Inc.
Sanofi SA
Takeda Pharmaceutical Company Limited
Viking Therapeutics, Inc.
VIVUS LLC
Zealand Pharma A/S

Table Information

Report Attribute	Details
No. of Pages	185
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 18.02 Billion
Forecasted Market Value ( USD ) by 2032	$ 29.46 Billion
Compound Annual Growth Rate	8.4%
Regions Covered	Global
No. of Companies Mentioned	26

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3501EUR$3,939USD£3,033GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3777EUR$4,249USD£3,272GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5119EUR$5,759USD£4,434GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6194EUR$6,969USD£5,366GBP

Market Snapshot: Obesity Treatment Market Growth, Size, and Prospects

Scope & Segmentation of the Obesity Treatment Market

Key Takeaways: Strategic Insights for Stakeholder Decision-Making

Assessing Tariff Impact on the Obesity Treatment Value Chain

Methodology & Data Sources

Why This Report Matters for the Obesity Treatment Market

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Obesity Diagnosis & Treatment Market - Global Forecast 2026-2032

Anti-obesity Prescription Drugs Market - Global Forecast 2026-2032

Obesity Market Report and Forecast 2025-2034

Global Digital Health For Obesity Market Size, Share & Industry Analysis Report By Component (Services, Software, and Hardware), By End-use (Patients, Providers, Payers, and Other End-use.), By Regional Outlook and Forecast, 2025 - 2032

Global Perspectives on Childhood Obesity. Current Status, Consequences and Prevention. Edition No. 2